Comment from Anonymous
AnonymousSupportIndividual
Summary: A veterinary professional argues that the current list of bulk drug substances for compounding is too restrictive and fails to meet the needs of many patients. They advocate for expanding the list to include more drugs and dosage forms to ensure timely and accurate treatment for animals, particularly those who cannot tolerate commercial products.
A significant percentage of my patients reject the commercial product.
Animals often refuse commercial liquid medications or cannot be accurately dosed with liquids due to refusal of a syringe, spitting, drooling, and/or the inability to gauge how much of the medication has been ingested.
Only a very restricted range of low-concentration oral suspensions are currently permitted for office use. This range of drugs is insufficient to meet the needs of animals who may require other dosage forms or strengths.
Tablet sizes of the commercial product are too large for many feline and small canine patients, resulting in compliance failure. Additionally, commercial tablet products cannot be split accurately into appropriate weight-based doses.
Animals left untreated while waiting 1-2 weeks for a patient-specific prescription may experience unresolved diarrhea containing blood and mucous, vomiting, lethargy, anorexia, and even death. Giardia infections, which are commonly treated with Metronidazole, have zoonotic potential and must be treated immediately to prevent human infection.